Moderna (MRNA) Surges 6.2%: Is This an Indication of Further Gains?Zacks Investment Research • 04/10/24
Moderna Reports Positive Results from Cancer Vaccine-Keytruda Combination TrialInvestopedia • 04/09/24
Moderna's stock jumps 6% as its cancer vaccine could treat more than just melanomaMarket Watch • 04/09/24
Is Moderna Stock A Buy As The Company Eyes The Covid Vaccine Market — Again?Investors Business Daily • 04/04/24
Phase 1/2 Interim Data on Moderna's mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia, Published in NatureAccesswire • 04/03/24
Moderna (MRNA) Posts Pipeline Progress, Secures Blackstone FundingZacks Investment Research • 03/28/24
Moderna moves three vaccines into final stage trials as it works to rebound from Covid slumpCNBC • 03/27/24